BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23611554)

  • 1. Traditional and novel dietary interventions for preventing progression of chronic kidney disease.
    Kovesdy CP
    J Ren Nutr; 2013 May; 23(3):241-5. PubMed ID: 23611554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy.
    Kovesdy CP; Kopple JD; Kalantar-Zadeh K
    Am J Clin Nutr; 2013 Jun; 97(6):1163-77. PubMed ID: 23636234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low-protein diet supplemented with keto acids on progression of chronic kidney disease.
    Garneata L; Mircescu G
    J Ren Nutr; 2013 May; 23(3):210-3. PubMed ID: 23611549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional therapy, phosphate control and renal protection.
    Carrero JJ; Cozzolino M
    Nephron Clin Pract; 2014; 126(1):1-7. PubMed ID: 24434650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light and shadows of dietary protein restriction in elderly with chronic kidney disease.
    Giordano M; Ciarambino T; Castellino P; Paolisso G
    Nutrition; 2013 Sep; 29(9):1090-3. PubMed ID: 23635802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diets for patients with chronic kidney disease, should we reconsider?
    Mitch WE; Remuzzi G
    BMC Nephrol; 2016 Jul; 17(1):80. PubMed ID: 27401192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic renal disease progression: treatment strategies and potassium intake.
    Sinha AD; Agarwal R
    Semin Nephrol; 2013 May; 33(3):290-9. PubMed ID: 23953806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keto-analogues and essential aminoacids and other supplements in the conservative management of chronic kidney disease.
    Cupisti A; Bolasco P
    Panminerva Med; 2017 Jun; 59(2):149-156. PubMed ID: 28001026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary management of chronic kidney disease: protein restriction and beyond.
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):635-40. PubMed ID: 23079747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease.
    Ripley E
    Am Heart J; 2009 Jun; 157(6 Suppl):S7-S16. PubMed ID: 19450722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Navigating between the Scylla and Charybdis of prescribing dietary protein for chronic kidney diseases.
    Franch HA; Mitch WE
    Annu Rev Nutr; 2009; 29():341-64. PubMed ID: 19575595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Nutrition and Malnutrition in CKD and ESRD.
    Zha Y; Qian Q
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients.
    Di Iorio BR; Bellizzi V; Bellasi A; Torraca S; D'Arrigo G; Tripepi G; Zoccali C
    Nephrol Dial Transplant; 2013 Mar; 28(3):632-40. PubMed ID: 23166309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stirring the Pot: Can Dietary Modification Alleviate the Burden of CKD?
    Snelson M; Clarke RE; Coughlan MT
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28287463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial.
    Cianciaruso B; Pota A; Bellizzi V; Di Giuseppe D; Di Micco L; Minutolo R; Pisani A; Sabbatini M; Ravani P
    Am J Kidney Dis; 2009 Dec; 54(6):1052-61. PubMed ID: 19800722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for setting medical nutrition therapy priorities for patients with stage 3 and 4 chronic kidney disease.
    Munson L
    J Ren Nutr; 2013 Mar; 23(2):e43-6. PubMed ID: 23337089
    [No Abstract]   [Full Text] [Related]  

  • 17. Does correction of metabolic acidosis slow chronic kidney disease progression?
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):193-7. PubMed ID: 23380803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary protein restriction and preservation of kidney function in chronic kidney disease.
    Kaysen GA; Odabaei G
    Blood Purif; 2013; 35(1-3):22-5. PubMed ID: 23343542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic kidney disease: therapy and care].
    Noel N; Gaha K; Rieu P
    Rev Prat; 2012 Jan; 62(1):43-51. PubMed ID: 22335066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can ACE inhibitors and angiotensin receptor blockers be detrimental in CKD patients?
    Onuigbo MA
    Nephron Clin Pract; 2011; 118(4):c407-19. PubMed ID: 21389735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.